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Abstract
Purpose Functional dyspepsia (FD) is a chronic condition
characterized by upper abdominal symptoms without an
identifiable cause. While the serotonergic system is thought
to play a key role in the regulation of gut physiology, the
role of the dopaminergic system, which is important in the
regulation of visceral pain and stress, is under-studied.
Therefore, this study investigated the dopaminergic system
and its relationship with drinking capacity and symptoms in
FD patients.
Methods In FD patients and healthy volunteers (HV) the
dopaminergic system was investigated by in-vivo assess-
ment of central dopamine D2 receptors (D2Rs) with [
123I]
IBZM SPECT and by an acute, but reversible, dopamine
depletion alpha-methyl-para-tyrosine (AMPT) challenge
test. A nutrient drink test was performed to investigate the
association between maximal ingested volume, evoked
symptoms, and D2Rs.
Results The HV subjects comprised 12 women and 8 men
(mean age 31±3 years), and the FD patients comprised 5
women and 3 men (mean age 39±5 years). The FD patients
had a lower left plus right average striatal binding potential
(BPNP) for the caudate nucleus (p00.02), but not for puta-
men (p00.15), which in the FD patients was correlated with
maximal ingested volume (r00.756, p00.03). The D2R
BPNP in the putamen was correlated with nausea (r00.857,
p00.01). The acute dopamine depletion test, however, failed
to reveal differences in prolactin release between the FD
patients and the HV subjects.
Conclusion These preliminary data suggest that chronic
rather than acute alterations in the dopaminergic system
may be involved in the pathogenesis of FD. Further studies
are required to reproduce our novel findings and to evaluate
to what extent the dopaminergic changes may be secondary
to abnormalities in serotonergic pathways.
Keywords Functionaldyspepsia.[
123I]IBZMSPECT.
DopamineD2receptor.Drinktest
Introduction
Functional dyspepsia (FD) is a chronic condition character-
ized by upper abdominal symptoms without an identifiable
cause. These symptoms include pain, early satiety, fullness,
bloating and nausea, and are usually related to food intake
[1]. Dyspeptic patients have increased sensitivity to
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DOI 10.1007/s00259-011-2015-6distension of the proximal stomach [2] and impaired relax-
ation of the stomach after food intake [3]. However, the
underlying mechanisms giving rise to gastric dysfunction
and dyspeptic symptoms remain to be unravelled.
Stress is generally accepted as an important factor trig-
gering or exacerbating dyspeptic symptoms [4]. In rodents,
acute stress has been associated with stress-induced visceral
analgesia [5], possibly by interfering with the processing of
sensory information in the brain. In the brain, pain, pleasure
and motivation (emotional cognitive function) are processed
in the mesolimbic system, including the ventral tegmental
area, nucleus accumbens and anterior cingulate cortex. In
particular because these brain areas are rich in dopamine D2
receptors (D2Rs) and activated by the neurotransmitter do-
pamine [6], dopaminergic pathways are considered impor-
tant in the regulation of (visceral) pain [7]. Moreover, stress
is known to have a detrimental impact on the normal func-
tion of the dopaminergic system [8]. Both acute and chronic
stress are able to influence levels of dopamine and dopamine
receptor function in rodents. However, the association be-
tween changes in the dopaminergic system and visceral pain
perception has not been investigated.
Another key factor in the regulation of gut physiology,
and the interaction with the brain, is the serotonergic (5-HT-
ergic) neurotransmission system. It has been suggested that
5-HT1A receptor hypersensitivity may play a role in FD,
which was supported by an increased release of prolactin
(PRL) after challenge with buspirone, an agonist of this
receptor [9]. However, buspirone is not only an agonist for
5-HT1A receptors, but also a partial antagonist for dopamine
D2Rs [10]. Inhibition of D2Rs can stimulate the release of
PRL as well. In chronic pain disorders, which are associated
with a hypodopaminergic system [11] and are related to FD
[12], an increased release of PRL, but not of growth hor-
mone, has been observed after a buspirone challenge test.
While the release of growth hormone by buspirone is only
mediated by stimulation of the 5-HT1A receptor, is has been
suggested that the increased release of PRL is a dopaminer-
gic and not a 5-HT-ergic effect [10]. In addition, in FD,
subsequent brain imaging PET studies have shown in-
creased activation of the mesolimbic system (among others
in the cingulated cortex) and deactivation of the pregenual
anterior cingulate after gastric distension [7, 13]. All these
pain-related brain areas are rich in D2Rs and (de)activation
of brain areas might correspond to a hypodopaminergic
system.
Based on the above, we hypothesized that abnormalities
in the central dopaminergic system could be involved in the
pathogenesis of FD. We therefore first analysed the in vivo
expression of central D2Rs using [
123I]iodobenzamide
([
123I]IBZM) SPECT in FD patients compared to that in
age- and gender-matched healthy volunteers (HV) [14]. In
addition, the response of the dopaminergic system to an
acute, but reversible, dopamine depletion was investigated
using the well-validated alpha-methyl-para-tyrosine
(AMPT) challenge test [15]. The advantage of this test is,
in contrast to buspirone, that AMPT only interferes with the
catecholaminergic system. Finally, on a separate day all
participants underwent a nutrient drink test to investigate
the correlation between maximal ingested volume, evoked
symptoms and the central D2Rs.
Materials and methods
Study population
Patients aged 18 to 65 years with a diagnosis of FD as
defined by the Rome III criteria [1] were recruited from
the gastrointestinal motility unit of the Academic Medical
Centre (AMC). Dyspeptic symptoms were scored using the
Nepean Dyspepsia Index (NDI) questionnaire [16], a vali-
dated method to assess FD symptoms. Based on previous
studies, only patients with a NDI score of >25 were included
[16, 17]. All patients underwent a careful history, physical
examination, upper endoscopy, blood investigation (includ-
ing thyroid-stimulating hormone, white blood cell count, C-
reactive protein) and abdominal ultrasonography. The HV
subjects, recruited by public advertisement, were included if
their NDI score was ≤5. Subjects with depression, as diag-
nosed with a score of >50 on the Zung self-rating depression
scale [18] and with concomitant diseases, such as diabetes
mellitus, epilepsy and cardiovascular disorders, were ex-
cluded. Other reasons for exclusion were previous abdomi-
nal surgery (except appendectomy and cholecystectomy),
gastrooesophageal reflux disease and concurrent use of
NSAIDs or antidepressants. Medication likely to interfere
with gastrointestinal function or the dopaminergic system
(prokinetics) and analgesics were discontinued at least
7 days before entering the study. In all female participants
pregnancy was excluded based on a clinical interview and
the β-human chorionic gonadotrophin (β-HCG) urine test.
The study protocol was approved by the Medical Ethics
Committee of the AMC, Amsterdam. All participants gave
their written and informed consent to participate in the
study.
Study protocols
The timeline of the study protocols is shown in Fig. 1.
SPECT imaging: data acquisition
After ingestion of potassium iodide (three doses of 40 mg on
the day before imaging and 80 mg just before imaging) to
block thyroid uptake of free radioactive iodide, the selective
Eur J Nucl Med Mol Imaging (2012) 39:642–650 643radiolabelled D2R antagonist [
123I]IBZM was infused using
the sustained equilibrium/constant infusion technique [14,
19]. First a [
123I]IBZM dose (specific activity >200 MBq/
nmol and radiochemical purity >95%) of approximately
64 MBq was given as a bolus, followed by a continuous
infusion of 48 MBq (dissolved in 0.9% NaCl) for the dura-
tion of the experiment (180 min). Acquisition of the images
(12–13 slices; 64×64 matrix) was started 2 h after the bolus
injection. Images were obtained with a 12-detector single-
slice brain-dedicated scanner (Neurofocus 810) with a full-
width at half-maximum resolution of approximately 6.5 mm
throughoutthe20-cmfieldofview(http://www.neurophysics.
com). After positioning the subject with the head parallel to
the orbitomeatal line, axial slices parallel to and upward from
the cerebellumtothe vertexwereacquiredin5-mmsteps.The
energy window was set at 135–190 keV. On the day of the
imaging session, the participants were not allowed to smoke
or to consume coffee or alcohol to avoid interference with
striatal dopamine release [20, 21].
SPECT imaging: data processing
Attenuation correction of all images was performed as de-
scribed previously [22]. Images were reconstructed in 3-D
mode. For quantification, a region-of-interest (ROI) analysis
of the two main striatal areas (the caudate nucleus and
putamen) was performed, as well as of the occipital cortex
(reflecting nonspecific binding). Standard templates
(according to the contour of the caudate nucleus, putamen
and occipital cortex) with fixed ROIs were manually posi-
tioned, without changing size and shape, on the five con-
secutive axial slices with the highest striatal activity to
calculated the mean striatal and mean occipital binding by
averaging right and left ROIs. The D2R binding potential
(BPNP [23]) was calculated for each striatal area as the ratio
of specific to nonspecific activity (total activity in each
striatal area minus total activity in the occipital cortex,
divided by total activity in the occipital cortex). BPNP for
the left and right striatal areas was calculated separately as
the ratio of specific to nonspecific activity (activity in left or
right striatal areas divided by the occipital activity). In
addition, an asymmetry index was calculated to determine
differences between the right and left side (activity in the
right minus activity in the left striatal area divided by the
sum of the right and left activity).
Dopamine depletion by AMPT challenge
Dopamine depletion was induced by oral administration of
AMPTusing a fixed total dose of 1,000 mg (four capsules of
250 mg) [15, 24] administered over 2 h, the first dose
(500 mg) given at noon and the second 2 h later. Blood
samples were collected via an intravenous catheter before
and every hour over the 4 h after AMPTadministration. The
degree of dopamine inhibition was indirectly measured by
PRL using a time-resolved fluoroimmunoassay (DELFIA
Prolactin; Wallac Oy, Turku, Finland). The total assay var-
iation ranged from 5.8% to 7.6%.
Nutrient drink test
On a separate day and after overnight fasting, participants
underwent a nutrient drink test [17] to evaluate the correla-
tion between maximal ingested volume, postprandial symp-
toms and striatal binding capacity.
Participants were asked to drink 100 ml of Nutridrink (N.
V. Nutricia; Zoetermeer, The Netherlands; 1.5 Kcal/ml, 39%
fat, 48% carbohydrates, 13% protein) every minute until
maximal satiation. After each 100 ml, symptoms of nausea,
bloating, satiety, fullness, burning sensation, pain and hun-
ger were scored on an ordinary symptoms scale ranging
from 0 (no sensation) to 5 (severe sensation). When subjects
reported a maximum score (5) for one of the symptoms, the
corresponding ingested volume was determined as the max-
imal ingested volume. Thereafter, symptoms were scored
every 30 min on a VAS scale (0–10 cm; 0 no sensation, 10
worst imaginable) until 3 h after the test. In addition, the
integrated VAS scores for each symptom were calculated by
adding each individual symptom (e.g. nausea, pain) during
the entire postprandial period, with a maximum score of 70.
The sum of these total scores yielded the total postprandial
symptom VAS scores (maximum 490).
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Fig. 1 Study protocol of
SPECT imaging and AMPT
challenge test in the 8 FD
patients and the 20 HV subjects
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Striatal D2R BPNP, ingested volume, postprandial symp-
toms, baseline PRL levels and baseline characteristics in-
cluding gender and age were compared between groups
using the Mann-Whitney U-test or the chi-squared test.
Spearman’s rho correlation coefficients were calculated to
investigate the relationship between striatal D2R BPNP, PRL
levels, maximal ingested volume and dyspeptic symptoms
(correlation coefficient R≥0.7 was considered relevant).
Ingested volumes, postprandial symptoms and PRL levels
were compared within groups using the nonparametric Wil-
coxon signed ranks test for paired samples. A two-tailed
probability value of 0.05 was considered as the significance
level. Statistical analyses were performed with SPSS, re-
lease 16.0.1 for Windows (SPSS, Chicago, IL).
Results
Study population
Eight FD patients and 20 HV subjects participated in the
SPECT imaging study. The two groups were comparable
and not significantly different regarding age and sex distri-
bution: the FD patients comprised 5 women (63%) and 3
men (mean age 39±5 years), and the HV subjects comprised
12 women (60%) and 8 men (mean age 31±3 years). In the
second part of the study, seven HV subjects declined to
participate in the nutrient drink test, dropped out and were
not included in the analysis of the drink test.
SPECT imaging
Compared to the 20 HV subjects, the 8 FD patients had a
significantly lower average left plus right striatal BPNP for
the caudate nucleus (p00.02), but not for the putamen (p0
0.15; Fig. 2). The asymmetry index (difference between left
and right side) was comparable between the FD patients and
HV subjects for the caudate nucleus (FD patients, −0.05,
range −0.1 to 0.1; HV subjects, −0.04, range −0.2 to 0.1;
NS) and the putamen (FD patients, 0.01, range −0.1 to 0.1;
HV subjects, −0.00, range −0.2 to 0.2; NS).
Dopamine depletion by AMPT challenge
At baseline, the median PRL levels were comparable be-
tween the groups (FD patients, 7.5 µg/l, range 2.0–12.5 µg/
l; HV subjects, 9.0 µg/l, range 5.0–17.0 µg/l; p00.06;
Fig. 3a). AMPTchallenge significantly increased PRL levels
compared to baseline in both groups (Fig. 3b, p<0.01). The
levels then slowly decreased, but were still elevated after 5 h.
However, there was no significant difference in PRL levels
between the FD patients and HV subjects. The maximum
PRL level was also comparable between the groups (FD
patients, 86 µg/l, range 59–130 µg/l; HV subjects, 87 µg/l,
30–185 µg/l; NS).
Drink test
In all FD patients and the 13 HV subjects who consented to
undergo the nutrient drink test, the maximal ingested vol-
ume was comparable (FD patients, 800 ml, range 200–
1,600 ml; HV subjects, 850 ml, range 350–1,500 ml; NS).
Symptoms including nausea, pain, satiety, fullness and
bloating were significantly increased in both groups com-
pared to their baseline values (p<0.03), whereas a burning
sensation was only increased in the HV subjects (p00.01)
after the nutrient drink. In the FD patients, nausea was
significantly increased compared to the HV subjects directly
after the drink test up to 120 min (p<0.04; Fig. 4). Pain and
bloating were also significantly increased in the FD patients
compared to the HV subjects at 30 and 120 min, respectively
(p<0.05). Other postprandial symptoms were comparable
between the groups (Fig. 4 and Supplementary Fig. S1).
In the FD patients, the integrated VAS score (sum of
scores at all time points) for nausea was significantly in-
creased (p<0.02) and tended to show an increase for pain
(p<0.06, Fig. 4 inset) compared to the scores in the HV
subjects. Similarly, the total postprandial score was signifi-
cantly increased in the FD patients compared to the score in
the HV subjects (FD patients, 205, range 53–220; HV sub-
jects, 96, range 42–150; p00.04). Other integrated VAS
scores were comparable between the groups (Supplementary
Fig. S1). Finally, the maximal ingested volume was neg-
atively correlated with the integrated VAS score for nau-
sea in the HV subjects (r0−0.681, p00.02), but not in
the FD patients (r00.296, p00.5; see, for example, Sup-
plementary Fig. S2). There was no correlation between
maximal ingested volume and the other integrated VAS
scores (data not shown).
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Fig. 2 BPNP of striatal D2R (average right plus left, R+L)i nt h e
8 FD patients and 20 HV subjects in the caudate nucleus and putamen.
The data are shown as medians+75th interquartile ranges (*p00.02,
Mann-Whitney U test)
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volume, postprandial symptoms and PRL levels
As the asymmetry index is comparable between the left and
right sides of the brain for each striatal area, correlations
were calculated for the average of the two sides. The aver-
age D2R BPNP for the caudate nucleus was significantly
correlated with maximal ingested volume (r00.756 p00.03)
in the FD patients, but not in the HV subjects (r0−0.211, p0
0.47). The correlation between the average D2R BPNP for the
putamen and the maximal ingested volume was of borderline
significance in the FD patients (r00.683, p00.06), but was
not significant in the HV subjects (r0−0.178, p00.54; Fig. 5).
Regarding evoked symptoms in the FD patients, the aver-
age D2R BPNP for the putamen was significantly correlated
with the integrated VAS score for nausea (r00.857, p00.01),
but there was nosignificant correlationinthe HVsubjects(r0
0.256, p00.422). This correlation was not significant in the
caudate nucleus (FD patients, r00.429, p00.34; HV subjects,
r00.343, p00.28; Fig. 6). Other (postprandial) symptoms
were not correlated with the average D2R BPNP in the striatal
areas in either group (data not shown).
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Fig. 4 Postprandial symptoms nausea, pain and bloating in the 8 FD
patients and 13 HV subjects. Insets Integrated VAS scores of postpran-
dial symptoms (sum of all VAS scores during the entire postprandial
period). Symptoms are shown as medians+75th interquartile ranges
(*p<0.04, Mann-Whitney U test)
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Fig. 3 PRL levels in FD
patients and HV subjects before
and after AMPT challenge. a
Individual baseline values
(horizontal lines medians; NS,
Mann-Whitney U test). b
Geometric mean values
following AMPT challenge (NS)
646 Eur J Nucl Med Mol Imaging (2012) 39:642–650Regarding PRL, there were no significant correlations
between the average D2R BPNP in either striatal area or
symptoms or maximal ingested volume in either group and
baseline PRL or maximum PRL levels. Similarly, there were
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(Spearman’s rho correlation
coefficients)
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PRL levels and postprandial symptoms or maximal ingested
volumes (data not shown).
Discussion
In the present study, we observed a lower D2R BPNP in the
caudate nucleus, one of the two main striatal areas, in FD
patients, which was significantly correlated with the maxi-
mal ingested volume during a drink test. Likewise, the D2R
BPNP in the putamen was significantly correlated with nau-
sea. After acute dopamine depletion, however, there were no
differences in PRL release between the HV subjects and FD
patients. These findings suggest that chronic rather than
acute alterations in the dopaminergic system may be in-
volved in the pathogenesis of FD. Further studies are, how-
ever, required to confirm this hypothesis.
It is widely recognized that stress is an important trigger
for functional bowel disorders, including FD [4]. Impor-
tantly, stress may alter the dopaminergic system [8] and is
particularly associated with lowered D2R binding in the
caudate nucleus [25, 26]. Using PET imaging, the caudate
nucleus has been shown to be activated by gastric disten-
sion, suggesting involvement of this brain area in visceral
perception [7, 13, 27]. In particular because the caudate
nucleus is rich in D2Rs, we hypothesized that altered dopa-
minergic transmission could be involved in the pathogenesis
of FD. To this end, we determined the D2R BPNP using
SPECT imaging in FD patients and HV subjects. The uptake
of radiolabelled D2R antagonist [
123I]IBZM [14] reflects the
proportion of D2Rs not occupied by endogenous dopamine,
and is therefore an indirect measure of endogenous dopami-
nergic tone, i.e. higher levels of endogenous dopamine are
associated with a lower binding potential of [
123I]IBZM,
according to the competition model [25].
In this study we showed that in patients with FD, D2R
binding in the caudate nucleus was significantly lower than
in healthy subjects, together with a tendency to have lower
basal PRL levels. Moreover, D2R binding was positively
associated with drinking capacity in FD patients. As previ-
ous studies have shown reduced drinking capacity in FD
patients compared to healthy subjects [17, 28], the finding
that reduced D2R binding is associated with reduced drink-
ing capacity would further suggest that an increased basal
dopaminergic tone may be involved in the pathogenesis of
FD. This is compatible with the observation that dopami-
nergic D2R/D3R antagonists, especially if they pass the
blood–brain barrier, for example metoclopramide, effective-
ly reduce nausea, which can be beneficial in FD patients
[29]. However, after meal intake (drink test), nausea scores
were positively correlated with D2R binding in FD patients.
These data would indicate that reduced rather than increased
release of dopamine is related to meal-induced nausea.
Moreover, reduced levels of dopamine may explain lower
D2R binding as well. For example, the most consistent
finding in cocaine addiction is a decrease in striatal D2Rs.
An elegant recent study using the AMPT challenge test,
however, has shown that this decrease could be attributed
to lower rather than higher levels of endogenous dopamine,
while the D2R binding capacity did not increase during
AMPT depletion [30]. Clearly, different mechanisms are
involved in the regulation of dopamine release and symptom
generation, but it also has to be emphasized that D2R
binding in the basal state may not reflect neurotransmitter
release during a physiological process such as food intake.
Therefore, further D2R imaging studies assessing D2R
availability before and after the use of AMPT are needed
to evaluate whether the lower D2R binding in FD patients as
observed in the present study could be attributed to higher
(or lower) levels of endogenous dopamine.
To further evaluate the hypothesis that dopaminergic
transmission in the striatum is altered in FD patients, the
effect of acute dopamine depletion by AMPT treatment [15,
24] on PRL release was investigated in both HV subjects
and FD patients. As PRL release is inhibited by dopamine,
acute dopamine depletion can be used to indirectly assess
the dopaminergic tone. As expected, AMPT challenge
resulted in a significant increase (almost ten times; Fig. 3)
in PRL levels, indicating that the dosage and infusion pro-
tocol used were indeed effective. However, no differences in
PRL release were detected between FD patients and HV
subjects. This finding is in contrast with the reduced D2R
BPND in the striatal areas observed in FD patients. One
explanation might be that imaging studies reflect the chronic
situation, while the AMPTcondition reflects a dopaminergic
response to an acute dopaminergic intervention. Alterna-
tively, these findings may indicate that the changes in the
dopaminergic system are not the primary cause of FD, but
may reflect a compensation for changes in another neuro-
transmitter system, e.g. the 5-HT-ergic system. In the brain,
the dopaminergic and 5-HT-ergic systems closely interact.
For example, compelling electrophysiological and neuro-
chemical data show that the main 5-HT control of the
activity of midbrain dopaminergic neurons is inhibitory
[31, 32]. Therefore, a possible increase in synaptic striatal
dopamine levels might not only be induced by increased
activity of midbrain dopaminergic neurons per se. A few
studies have investigated indirectly the 5-HT-ergic system in
FD patients by a buspirone challenge test [9] or a cholecys-
tokinin challenge test [33]. These studies showed an in-
creased perception of visceral sensation after the challenge,
probably caused by hypersensitive 5-HT receptors, in
particular the 5-HT1 receptor. Stimulation of the 5-HT1 re-
ceptor negatively affects the synthesis and release of endoge-
nous 5-HT [34]. Consequently, hypersensitivity of the 5-HT1
648 Eur J Nucl Med Mol Imaging (2012) 39:642–650receptor may induce decreased production of 5-HT leading to
higher dopamine levels [34]. Interestingly, (acute) tryptophan
depletion leads to increased visceral sensitivity in patients
with irritable bowel syndrome and in controls [35, 36], indi-
cating an important role for reduced 5-HT-ergic transmission
inirritable bowel syndrome. Therefore, wecannotexclude the
possibility that our present observation of lowered striatal
D2R binding induced by altered levels of dopamine may be
caused by a hyposerotonergic system, and may rather reflect a
compensatory mechanism.
The following limitations of the study should be men-
tioned. Firstly, the number of patients studied was rather low
leading to the risk of a type II error, and therefore our findings
need to be confirmed. Moreover the low numbers of patients
might explain the discrepancy between the putamen and cau-
date nucleus. Secondly, striatal D2R binding was assessed
using SPECT. Novel high-affinity PET tracers for dopamine
D2Rs are now available making the measurement of extra-
striatal D2Rs also feasible. Given the role of the anterior
cingulatecortexandthemid-cingulatedcortexinpaininduced
by rectal distension [37] and gastric distension [7, 38], it
would be of great interest to examine dopamine D2R binding
in these brain areas. Furthermore, the spatial resolution of
SPECT is lower than that of PET, although we used a brain-
dedicated system with a high spatial resolution. However,
IBZM SPECT is a well-validated reproducible method for
measuring D2Rs in the striatum [19, 22, 39]. Finally, a
strength of our study is that we used a bolus/infusion tech-
nique to assess in vivo dopamine D2R binding [14]. This
approach is not sensitive to changes in cerebral blood flow,
and measures D2Rs in a state of equilibrium.
In conclusion, we are the first to show decreased striatal
D2R binding in the caudate nucleus in FD patients. D2R
binding capacity in FD patients was significantly correlated
with drinking capacity and evoked nausea suggesting the
involvement of altered, probably increased, dopaminergic
transmission in the striatum in the pathophysiology of FD.
However, to what extent this may be secondary to abnor-
malities in serotonergic pathways remains to be investigat-
ed. We believe that our findings will initiate further studies
on the possible role of alterations of the dopaminergic as
well as the serotonergic system in the induction of FD,
which may eventually lead to a more individualized treat-
ment of FD.
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